Assura Plc (LON:AGR – Get Free Report) insider Jayne Cottam bought 363 shares of the company’s stock in a transaction on Wednesday, March 5th. The shares were purchased at an average cost of GBX 41 ($0.53) per share, for a total transaction of £148.83 ($191.79).
Jayne Cottam also recently made the following trade(s):
- On Wednesday, February 5th, Jayne Cottam purchased 405 shares of Assura stock. The shares were acquired at an average cost of GBX 37 ($0.48) per share, with a total value of £149.85 ($193.11).
Assura Stock Performance
Shares of Assura stock opened at GBX 40.29 ($0.52) on Friday. The firm has a market capitalization of £1.31 billion, a P/E ratio of -38.51, a price-to-earnings-growth ratio of 3.60 and a beta of 0.37. The company has a current ratio of 0.89, a quick ratio of 2.84 and a debt-to-equity ratio of 85.05. The business’s fifty day simple moving average is GBX 38.64 and its 200 day simple moving average is GBX 39.79. Assura Plc has a 12 month low of GBX 35.24 ($0.45) and a 12 month high of GBX 46.20 ($0.60).
About Assura
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.
Recommended Stories
- Five stocks we like better than Assura
- Investing In Preferred Stock vs. Common Stock
- Investing in Small-Cap AI: Powering the Next Tech Revolution
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
- The Basics of Support and Resistance
- Super Micro Computer Is Now NASDAQ Compliant—But Is It a Buy?
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.